Navigation Links
Cranberry-Active Proven to Treat and Prevent Vaginal Infections

AMSTERDAM, April 22, 2013 /PRNewswire/ --

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts

Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented Cranberry-Active tablet, making it the first and only cranberry-based product in Europe which has a proven medical claim to treat and prevent vaginal infections.

After the successful introduction of Cranberry-Active capsules for the treatment of bladder- and urinary tract infections in 2012, Medical Brands and American company NATUREX-DBS together have introduced their latest development for treatments of vaginal infections.

,,Vaginal Infections are a serious health problem, affecting one of every three women during their lifetime," says Maikel Hendriks, president of Medical Brands. ,,After the first treatment, another 30 percent will suffer from re-occurrence within three months and 80 percent within nine months."

While the claims of other cranberry-based food supplements and pro-biotic vaginal products have been rejected by the European Food and Safety Authority (EFSA), Medical Brands produced studies which clinically showed that the Cranberry-Active treats and prevents vaginal infections. The product can be freely sold as a self-care medical device on the OTC market in all European countries.

Maikel Hendriks: ,,Our Cranberry-Active marketing authorization is the culmination of years of planning, development and clinical investigation. We answer to a growing global push towards safe and natural solutions as the resistance to antibiotics continues to rise."

His company is specialised in developing self-care medical devices without pharmacologic effects. It provides consumers with solutions for everyday diseases without the side effects that most drugs have.

In the Netherlands and Scandinavia the tablet is sold as the Vaginal Infection Tablet by 'i say'. In other countries Medical Brands is still searching for partners to distribute the products.

SOURCE Medical Brands
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cranberry-Active démontre sa capacité à traiter et prévenir les infections vaginales
2. Cranberry-Active wirksam zur Behandlung und Vorbeugung vaginaler Infektionen
3. Cranberry Capsule Proven to Cure Bladder Infection
4. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Post Your Comments:
(Date:12/1/2015)... Sensor Networks, a leader in intelligent sensors and analytic software for sensor network-based systems, announced ... data collection of vital signs. Photo - ... ... ... ...
(Date:12/1/2015)... , Dec. 1, 2015 Ampio Pharmaceuticals, ... York Stock Exchange has established January 5, 2016 as the ... stockholders of the shares of Common Stock of Aytu ... share of Aytu common stock for every five (5) ... record date, December 1, 2015. The distribution date will be ...
(Date:12/1/2015)... Sweden , December 1, 2015 ... International Breast Cancer Study Group (IBCSG, Bern ... ) to be part of a state of the ... cancer drug.  --> --> ... cancer being treated with anti-hormonal therapy in combination with palbociclib, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... Next IT Healthcare, the leader in patient ... year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of ... the category of Digital Solutions for its innovative, industry-leading product, Alme Health Coach. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Lutronic, a ... of Clarity, the latest addition to the devices for sale in the United States. ... nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... SACC-GA and SACC-USA through membership and leadership since 2008. Gary Bruce, President ... SACC-USA . Gary has spent a significant amount of time in Sweden ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., ... largest order to date. , The order will be from the China Disabled ... Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):